Yale’s Colton Center for Autoimmunity Announces 2025 Awardees Advancing Innovation in Autoimmune Disease Research
Yiviva Presents Phase 2b Results for YIV-906 in Combination with Sorafenib in Advanced Hepatocellular Carcinoma at ASCO and ESMO GI 2025
Biohaven Pharma (BHVN) Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day
Yale Innovation Summit adds ‘Civic’ track to spotlight innovations that address ‘society’s challenges’